Cerebral venous sinus thrombosis secondary prevention: Difference between revisions
(Created page with "__NOTOC__ {{Cerebral venous sinus thrombosis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. == R...") |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
{{Cerebral venous sinus thrombosis}} | {{Cerebral venous sinus thrombosis}} | ||
Associate editor in chief: {{SharmiB}} | |||
== References == | == Overview == | ||
For patients with [[cerebral venous thrombosis]], a long-term [[anticoagulant]] is highly recommended to prevent future events. | |||
==Secondary prevention== | |||
Long term [[anticoagulant]] should be considered in patients with history of [[pulmonary]] [[thrombosis]] or [[deep venous thrombosis]].<ref name="van NuenenMunneke2005">{{cite journal|last1=van Nuenen|first1=B.F.L.|last2=Munneke|first2=M.|last3=Bloem|first3=B.R.|title=Cerebral Venous Sinus Thrombosis: Prevention of Recurrent Thromboembolism|journal=Stroke|volume=36|issue=9|year=2005|pages=1822–1823|issn=0039-2499|doi=10.1161/01.STR.0000176582.17934.82}}</ref> | |||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 17:07, 1 August 2021
Cerebral venous sinus thrombosis Microchapters |
Differentiating Cerebral venous sinus thrombosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cerebral venous sinus thrombosis secondary prevention On the Web |
American Roentgen Ray Society Images of Cerebral venous sinus thrombosis secondary prevention |
FDA on Cerebral venous sinus thrombosis secondary prevention |
CDC on Cerebral venous sinus thrombosis secondary prevention |
Cerebral venous sinus thrombosis secondary prevention in the news |
Blogs on Cerebral venous sinus thrombosis secondary prevention |
Directions to Hospitals Treating Cerebral venous sinus thrombosis |
Risk calculators and risk factors for Cerebral venous sinus thrombosis secondary prevention |
Associate editor in chief: Sharmi Biswas, M.B.B.S
Overview
For patients with cerebral venous thrombosis, a long-term anticoagulant is highly recommended to prevent future events.
Secondary prevention
Long term anticoagulant should be considered in patients with history of pulmonary thrombosis or deep venous thrombosis.[1]
References
- ↑ van Nuenen, B.F.L.; Munneke, M.; Bloem, B.R. (2005). "Cerebral Venous Sinus Thrombosis: Prevention of Recurrent Thromboembolism". Stroke. 36 (9): 1822–1823. doi:10.1161/01.STR.0000176582.17934.82. ISSN 0039-2499.